Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MGNX
MGNX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MGNX News
Sanofi Appoints New Head of R&D Amid Dividend Stock Recognition
2d ago
Yahoo Finance
MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals
6d ago
Newsfilter
MacroGenics Receives $24.5 Million Milestone Payment
Jun 23 2026
NASDAQ.COM
Sanofi Pays MacroGenics $24.5M Milestone for Tzield Approval
Jun 22 2026
seekingalpha
MacroGenics Receives $24.5 Million Milestone Payment from Sanofi
Jun 22 2026
Newsfilter
VERAXA Biotech Secures $27.5 Million Financing Agreement
May 28 2026
Yahoo Finance
MacroGenics Q1 Earnings Beat Expectations with Revenue Growth
May 13 2026
seekingalpha
MacroGenics Sells GMP Drug Manufacturing to Bora for $122.5 Million
May 12 2026
seekingalpha
MacroGenics Enters $122.5 Million Agreement with Bora Pharmaceuticals
May 11 2026
Newsfilter
MacroGenics Expands Royalty Purchase Agreement with Sagard Healthcare Partners
May 04 2026
seekingalpha
MacroGenics Expands Royalty Agreement with Sagard for ZYNYZ
May 04 2026
Newsfilter
MGNX Positioned for Growth in Antibody-Drug Conjugate Market
Apr 10 2026
stocktwits
Macrogenics Shares Rise as FDA Lifts Clinical Hold on Lorigerlimab Trial
Apr 09 2026
seekingalpha
MacroGenics FDA Lifts Partial Hold on LINNET Study
Apr 09 2026
NASDAQ.COM
MacroGenics Resumes Lorigerlimab Clinical Study Enrollment
Apr 08 2026
Newsfilter
MacroGenics Stock Surpasses Analyst Target Price
Mar 11 2026
NASDAQ.COM
Show More News
